WASHINGTON, Aug. 17 (TNSrep) -- The Congressional Research Service issued the following report (No. R47217) on Aug. 16, 2022, entitled "Community Development Financial Institutions: Overview and Selected Issues" by financial economics specialist Darryl E. Getter. Here are excerpts: * * * SUMMARY The Community Development Financial Institutions (CDFI) Fund was created by the Riegle Community Development Regulatory Improvement Act of 1994 (P.L. 103-325) to promote economic development in distr  more

WASHINGTON, Aug. 17 (TNSrep) -- The Congressional Research Service issued the following report (No. R47217) on Aug. 16, 2022, entitled "Community Development Financial Institutions: Overview and Selected Issues:" * * * (Continued from Part 2 of 3) Public and Private Funding Sources This section summarizes the public and private funding sources for CDFIs. For sake of comparison, the textbox below summarizes how traditional intermediaries obtain the funds to serve their clients with more stand  more

BOSTON, Massachusetts, Aug. 17 -- The FBI Boston Field Office issued the following news release: On Tuesday, August 16, 2022, FBI Director Christopher A. Wray visited the FBI Boston Division's Portland, Maine, Resident Agency and met with Special Agent in Charge Joseph R. Bonavolonta and office personnel. He also met with local, state, and federal law enforcement partners to affirm the FBI's continued commitment to help combat violent crime, hate crimes, homegrown violent extremism, and raciall  more

WALTHAM, Massachusetts, Aug. 16 -- The New England Journal of Medicine, a peer-reviewed medical journal from the the Massachusetts Medical Society that says it delivers research and interactive clinical content to physicians, educators and the global medical community, published research articles on the following topics in its Aug. 11, 2022 edition: Perspectives: * Considering Race and Ethnicity in Covid Risk Assessments -- Legal Concerns and Possible Solutions * Understanding Covid Vaccine   more

UNIVERSITY CITY, Pennsylvania, Aug. 17 (TNSres) -- The University of Pennsylvania's Perelman School of Medicine issued the following news release: * * * Clinical trial brings hope for those with cutaneous lupus erythematosus, Penn Medicine researchers find * * * An experimental drug called litifilimab (known as BIIB059) could be a powerful long-term treatment for cutaneous lupus erythematosus (CLE), a form of lupus that occurs in the skin and can severely impact quality of life, according to  more